# Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00012051** · PHASE3 · COMPLETED · sponsor: **Commissie Voor Klinisch Toegepast Onderzoek** · enrollment: 340 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** rituximab
- **DRUG:** carmustine
- **DRUG:** cisplatin
- **DRUG:** cytarabine
- **DRUG:** dexamethasone
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** melphalan
- **DRUG:** methotrexate
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00012051
- **Lead sponsor:** Commissie Voor Klinisch Toegepast Onderzoek
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00012051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00012051, "Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00012051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*